Artificial Intelligence

Artificial intelligence, or AI, is an umbrella term for machine learning and deep learning. It is where a machine takes in information from its surroundings and, from that, makes the most optimal decision appropriate to the situation.

AI in Food: How Artificial Intelligence is Designing Healthier and More Sustainable Foods

Artificial intelligence is transforming food innovation by accelerating ingredient discovery, optimizing formulations, and enabling personalized nutrition strategies to improve public health outcomes. AI-driven tools also support food safety assessment, sustainable food systems, and precision nutrition while raising important governance, equity, and validation challenges.

Artificial Intelligence in Histopathology

The Pros and Cons of Healthcare Chatbots

Artificial Intelligence in Cardiology

AI-Powered Genomic Analysis: Revolutionizing the Detection of Genetic Mutations

The Medical Industries That Are Most Likely to Be Impacted by Ai

Deep-Learning in Radiology

Can Artificial Intelligence be used to Diagnose Brain Aneurysms?

AI Psychosis: How Artificial Intelligence May Trigger Delusions and Paranoia

Uncovering the Mystery of the Human Brain with Computational Neuroscience

How Artificial Intelligence Is Revolutionizing Emergency Medicine

Artificial Intelligence in CBT

See more featured articles »

Applying Deep Learning to Localization Microscopy

Machine Learning in Drug Development

Is Data at the Center of Healthcare for the Future?

Artificial Intelligence and Life Science

What does ChatGPT mean for Healthcare?

Managing the Explosion of Healthcare Data to Harness its Power

Beyond Virtual Consultations: The Rise of AI-Driven Virtual Healthcare Assistants

The Role of AI in Pathogen Detection and Epidemic Prediction

Recent Developments in Health Technology

Artificial Intelligence and Deep Learning in Medicine

Ethical Considerations in AI-Driven Healthcare

Latest Artificial Intelligence News and Research

Harvard scientists design evolutionary traps to stop viral mutations

When a virus mutates, the world usually finds out the hard way. Variants of influenza and SARS‑CoV‑2 can slip past vaccines and antibody drugs before scientists fully understand what has changed.

15 Sep 2026

AI scribes slash physician documentation time and reduce burnout

Artificial intelligence (AI) scribes can reduce the time physicians spend documenting patient visits by 69.1% during simulated primary care appointments, according to research led by University of Toronto PhD student LaShawn Murray.

15 Sep 2026

Study raises questions about AI's role in decision support for ethically sensitive situations

Artificial intelligence (AI) models prioritize starkly different attributes than humans when making high-stakes decisions, and they don't express indecision like humans do, according to a new study led by Penn State researchers, raising questions about the role of AI in decision support for ethically sensitive situations like medical decisions.

15 Sep 2026

Advanced AI cell models redefine modern cell biology research

Researchers at Stanford Medicine have developed two new artificial intelligence models of the biological cell.

15 Sep 2026

Cardiovascular disease surpasses cancer as top killer of Hispanic populations in the U.S.

Cardiovascular disease has surpassed cancer as the leading cause of death among Hispanic adults in the U.S., driven by rising rates of obesity, diabetes, high blood pressure and other risk factors that often begin earlier in life for Hispanic people.

15 Sep 2026

Insilico Medicine launches AI initiative to develop longevity vaccines

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced Longevity Vaccines, a research initiative developing treatments that direct a patient's own immune cells to eliminate the earliest cellular drivers of age-related disease.

15 Sep 2026

New brain computer interface restores simultaneous speech and physical gestures

A National Institutes of Health (NIH)-funded scientific team has shown that a new brain-computer interface (BCI) can allow people with vocal tract and bodily paralysis to convey both speech and upper-body gestures simultaneously.

15 Sep 2026

Bacterial strains determine pneumonia and meningitis risk from air pollution

Air pollution leads to different risk of bacterial pneumonia, sepsis, and meningitis, depending on the subtype of bacteria a person has, new research suggests.

15 Sep 2026

More hospitals are adopting AI, yet the access gap is proving hard to close

A national analysis of 6,166 US hospitals found that specific workflow AI capabilities were associated with higher sepsis bundle completion rates and lower 30-day pneumonia mortality, whereas robotics showed narrower procedural associations. Geographic access remained highly uneven, with about 114.6 million people in the access-analysis population living more than 30 minutes from an AI-enabled hospital, although the observational design prevents causal conclusions.

14 Sep 2026

New AI model maps billions of years of protein evolution

An international team of researchers, including Earth-Life Science Institute (ELSI) at the Institute of Science Tokyo, has developed a protein language model that brings together two fundamental sources of information about proteins: their amino acid sequences and their three-dimensional structures.

11 Sep 2026

Neighborhood environments impact long-term health of 9/11 responders

Twenty-five years after the September 11 terrorist attacks, researchers at the Icahn School of Medicine at Mount Sinai have found that environmental conditions where World Trade Center responders live may influence their long-term physical and mental health.

11 Sep 2026

Proteomic signatures reveal early signs of cardiovascular-kidney-metabolic disease in children

Researchers at Vanderbilt Health, UTHealth Houston and the University of North Carolina at Chapel Hill have identified early signs of cardiovascular-kidney-metabolic disease (CKMD) in children as young as 8 years old that potentially can be reversed with a new class of weight loss drugs used widely by adults

11 Sep 2026

AI identifies hidden biological patterns to accurately diagnose migraines

AI can trawl vast amounts of health data which is not specifically related to migraines, but which can be used to identify people predisposed to the condition.

11 Sep 2026

Experts examine ethical risks of using AI in public health

Artificial intelligence (AI) holds profound potential to reshape public health. Although its application accelerates threat detection and targeted interventions, the rapid deployment has outpaced the regulatory, validation, and equity safeguards standard to traditional health interventions.

10 Sep 2026

Review highlights solute carriers as targets for central nervous system disorders

Solute carriers (SLCs) are specialized transport proteins that control the movement of nutrients, ions and neurotransmitters across cell membranes and are essential for brain metabolism and neuronal communication.

10 Sep 2026

New AI tool predicts breast cancer risk using repeated 3D mammograms

An artificial intelligence model that analyzes women's past and recent annual 3D mammograms is more effective at predicting five-year risk of developing breast cancer than a tool that uses only the most recent, single 3D mammogram, as well as an AI model that analyzes 2D mammograms, a new study shows.

10 Sep 2026

Generative AI-driven drug Rentosertib enters Phase III trial for idiopathic pulmonary fibrosis

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, today announced that it has dosed the first patient with Rentosertib (known as ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial (NCT07687459, CTR20262475) at Peking Union Medical College Hospital, while Shanghai Pulmonary Hospital has also enrolled its first patient on the same day.

10 Sep 2026